Amrinone, a Selective Phosphodiesterase III Inhibitor, Improves Microcirculation and Flap Survival: A Comparative Study with Prostaglandin E₁

By Ichioka S.   Nakatsuka T.   Sato Y.   Shibata M.   Kamiya A.   Harii K.  

Journal of Surgical Research, Vol. 75, Iss. 1, 1998-02 ,pp. : 42-48

Academic Press

Access to resources Recommend Favorite

Effects of TJN-598, a new selective phosphodiesterase type IV inhibitor on anti-Thy1 nephritis in rats

By Sadakane Chiharu   Kase Yoshio   Koseki Junichi   Hasegawa Yoshihiro   Shindo Shoichiro   Maruyama Hirobumi   Takeda Shuichi   Takeda Hiroshi   Hattori Tomohisa  

Clinical and Experimental Nephrology, Vol. 15, Iss. 1, 2011-02 ,pp. : 14-24

Springer Publishing Company

Access to resources Recommend Favorite

Cardioprotection induced by olprinone, a phosphodiesterase III inhibitor, involves phosphatidylinositol-3-OH kinase-Akt and a mitochondrial permeability transition pore during early reperfusion

By Tosaka Shinya   Makita Tetsuji   Tosaka Reiko   Maekawa Takuji   Cho Sungsam   Hara Tetsuya   Ureshino Hiroyuki   Sumikawa Koji  

Journal of Anesthesia, Vol. 21, Iss. 2, 2007-05 ,pp. : 176-180

Springer Publishing Company

Access to resources Recommend Favorite

Phosphodiesterase 4 inhibitor rolipram potentiates the inhibitory effect of calcitonin on osteoclastogenesis

By Miyamoto Ken-ichi   Nishioka Tatsuo   Waki Yoshihiro   Nomura Masaaki   Katsuta Hiromu   Yokogawa Koichi   Amano Hitoshi  

Journal of Bone and Mineral Metabolism, Vol. 24, Iss. 4, 2006-07 ,pp. : 260-265

Springer Publishing Company

Access to resources Recommend Favorite

Effect of a Selective Cyclooxygenase-2 Inhibitor on Renal Scarring

By  

European Surgical Research, Vol. 38, Iss. 5, 2006-10 ,pp. : 451-457

Karger

Access to resources Recommend Favorite